Chemistry:LG-2527

From HandWiki
Revision as of 13:39, 6 March 2023 by TextAI (talk | contribs) (add)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
LG-2527
Clinical data
Drug classProgestin; Progestogen

LG-2527 is a nonsteroidal progestin which was under development by Ligand Pharmaceuticals and Wyeth for the treatment of menopausal symptoms and breast cancer but was never marketed.[1] It reached the preclinical stage of development prior to the discontinuation of its development in early 2001.[1]

References